LOS ANGELES CAPITAL MANAGEMENT LLC
Position in BMRN — Biomarin Pharmaceutical Inc
CIK 1177206
LOS ANGELES, CA
Position in BMRN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$39,869,980
+$16,857,141 QoQ
Shares Held
696,784
+71.0% QoQ
Ownership
0.360%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#44
of 561 holders
Holding Since
Mar 2020
14 quarters on record
Voting authority
Sole 78%
Shared 0%
None 22%
Common Shares in BMRN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026LOS ANGELES CAPITAL MANAGEMENT LLC holds $888,562,834 across 167 Biotechnology names. BMRN ranks #9 (4.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
729,635 | $219,642,024 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,938,035 | $151,689,999 | |
| 3 | CAI |
Caris Life Sciences, Inc.
|
3,958,531 | $70,541,022 | |
| 4 | INCY |
Incyte Corp
|
578,986 | $65,633,852 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
130,802 | $64,973,277 | |
| 6 | EXEL |
Exelixis, Inc.
|
1,159,457 | $63,086,055 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
98,585 | $61,471,690 | |
| 8 | RPRX |
Royalty Pharma plc
|
877,674 | $49,211,181 |
All Filings in BMRN
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $39,869,980 | 696,784 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $23,012,839 | 407,379 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $66,068,212 | 1,111,698 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $72,162,675 | 1,332,398 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $15,292,049 | 278,189 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $9,971,107 | 141,054 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $2,532,511 | 38,529 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $709,788 | 10,098 | Shares | Sole | 2024-11-04 | |
| 2023-12-31 | $666,358 | 6,911 | Shares | Sole | 2024-02-06 | |
| 2023-06-30 | $5,385,081 | 62,126 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $7,361,943 | 75,709 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $7,960,554 | 76,921 | Shares | Sole | 2023-02-06 | |
| 2020-06-30 | $1,673,723 | 13,570 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $926,796 | 10,968 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||